Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 60878 [2013-24062]

Download as PDF 60878 Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices For Further Information Contact: Felicia Betancourt, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., MS–A27, Atlanta, Georgia 30333, telephone 404/639– 8836; Email ACIP@CDC.GOV The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24061 Filed 10–1–13; 8:45 am] Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–3585, Email: EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Telephone: (770) 488–3585, Email: EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24062 Filed 10–1–13; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2013–24067 Filed 10–1–13; 8:45 am] BILLING CODE 4160–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review tkelley on DSK3SPTVN1PROD with NOTICES The meeting announced below concerns Health Promotion and Disease Prevention Research Centers, Funding Opportunity Announcement (FOA) DP14–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates 8 a.m.–6:30 p.m., November 18, 2013 (Closed) 8 a.m.–6:30 p.m., November 19, 2013 (Closed) 8 a.m.–6:30 p.m., November 20, 2013 (Closed) 8 a.m.–6:30 p.m., November 21, 2013 (Closed) Place: Centers for Disease Control and Prevention, 1600 Clifton Road NE., Global Communications Center, Auditorium B, Atlanta, Georgia 30333. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Health Promotion and Disease Prevention Research Centers, FOA DP14–001’’. For Further Information Contact: M. Chris Langub, Ph.D., Scientific Review VerDate Mar<15>2010 17:48 Oct 01, 2013 Jkt 232001 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Health Promotion and Disease Prevention Research Centers, Funding Opportunity Announcement (FOA) DP14–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times And Dates 8 a.m.–6:30 p.m., November 18, 2013 (Closed); 8 a.m.–6:30 p.m., November 19, 2013 (Closed); 8 a.m.–6:30 p.m., November 20, 2013 (Closed); 8 a.m.– 6:30 p.m., November 21, 2013 (Closed). Place: Centers for Disease Control and Prevention, 1600 Clifton Road NE., Global Communications Center, Auditorium B, Atlanta, Georgia 30333. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Health Promotion and Disease Prevention Research Centers, FOA DP14–001’’. For Further Information Contact: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns National Center for Construction Safety and Health Research and Translation (U60, Request for Application (RFA) OH13–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., November 19, 2013 (Closed); 8 a.m.–5 p.m., November 20, 2013 (Closed); 8 a.m.–12 p.m., November 21, 2013 (Closed). Place: Embassy Suites Alexandria Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: (703)842– 7030. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘National Center for Construction Safety and Health Research and Translation (U60), RFA OH13–001.’’ For Further Information Contact: George Bockosh, M.S., Scientific Review Officer, CDC/NIOSH, 626 Cochrans Mill Road, Mailstop P–05, Pittsburgh, Pennsylvania 15236, Telephone: (412) E:\FR\FM\02OCN1.SGM 02OCN1

Agencies

[Federal Register Volume 78, Number 191 (Wednesday, October 2, 2013)]
[Notices]
[Page 60878]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24062]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Health Promotion and Disease 
Prevention Research Centers, Funding Opportunity Announcement (FOA) 
DP14-001, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

Times And Dates

    8 a.m.-6:30 p.m., November 18, 2013 (Closed); 8 a.m.-6:30 p.m., 
November 19, 2013 (Closed); 8 a.m.-6:30 p.m., November 20, 2013 
(Closed); 8 a.m.-6:30 p.m., November 21, 2013 (Closed).
    Place: Centers for Disease Control and Prevention, 1600 Clifton 
Road NE., Global Communications Center, Auditorium B, Atlanta, Georgia 
30333.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``Health Promotion and Disease 
Prevention Research Centers, FOA DP14-001''.
    For Further Information Contact: M. Chris Langub, Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80, Atlanta, 
Georgia 30341, Telephone: (770) 488-3585, Email: EEO6@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-24062 Filed 10-1-13; 8:45 am]
BILLING CODE 4163-18-P